Giacomo Coltro

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Venues

American journal of hematology

Blood

Bioengineering (Basel, Switzerland)

Blood cancer journal

Azienda Ospedaliero Universitaria Careggi

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Azienda Ospedaliero Universitaria Careggi Nov 01 2015

Italy

Resident :: Hematology

Publications

Giacomo Coltro, Raffaella Santi
A challenging diagnosis of myeloid/lymphoid neoplasm with eosinophilia and FIP1L1::PDGFRA rearrangement. Blood 141 (20) (2023)
Giuseppe Gaetano Loscocco, Giada Rotunno, Francesco Mannelli, Giacomo Coltro, Francesca Gesullo, Fabiana Pancani, Leonardo Signori, Chiara Maccari, Maria Esposito, Chiara Paoli, Alessandro Maria Maria Vannucchi, Paola Guglielmelli
The prognostic contribution of CBL, NRAS, KRAS, RUNX1, and TP53 mutations to mutation-enhanced international prognostic score systems (MIPSS70/plus/plus v2.0) for primary myelofibrosis. American journal of hematology (2023)
Matteo Piccini, Francesco Mannelli, Giacomo Coltro
The Role of Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Past, Present, and Future Directions. Bioengineering (Basel, Switzerland) 10 (5) (2023)
Edoardo Peroni, Michele Gottardi, Lucia D'Antona, Maria Luigia Randi, Antonio Rosato, Giacomo Coltro
Hematologic Neoplasms Associated with Down Syndrome: Cellular and Molecular Heterogeneity of the Diseases. International journal of molecular sciences 24 (20) (2023)
Giacomo Coltro, Emanuela Sant'Antonio, Giuseppe A Palumbo, Francesco Mannelli, Valerio De Stefano, Marco Ruggeri, Elena Maria Elli, Roberta Zanotti, Oscar Borsani, Irene Bertozzi, Andrea Duminuco, Silvia Betti, Giuseppe Carli, Fabrizio Cavalca, Ilaria Tanasi, Elisa Rumi, Maria L Randi, Bruno Garibaldi, Giuseppe Gaetano Loscocco, Paola Guglielmelli, Alessandro M Vannucchi
Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real-life setting: An Italian MYNERVA Project. Cancer medicine (2023)
Giacomo Coltro, Raffaella Santi
A challenging diagnosis of myeloid/lymphoid neoplasm with eosinophilia and FIP1L1::PDGFRA rearrangement. Blood 141 (20) (2023)
Giacomo Coltro, Francesco Mannelli, Giuseppe Gaetano Loscocco, Carmela Mannarelli, Giada Rotunno, Chiara Maccari, Fabiana Pancani, Alessandro Atanasio, Alessandro Maria Maria Vannucchi, Paola Guglielmelli
Differential prognostic impact of cytopenic phenotype in prefibrotic vs overt primary myelofibrosis. Blood cancer journal 12 (8) (2022)
Paola Guglielmelli, Giacomo Coltro, Francesco Mannelli, Giada Rotunno, Giuseppe Gaetano Loscocco, Carmela Mannarelli, Chiara Maccari, Chiara Paoli, Simone Romagnoli, Bartalucci Niccolò, Alessandro Maria Maria Vannucchi
ASXL1 mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia vera. Blood advances 6 (9) (2022)
Giacomo Coltro, Guadalupe Antelo, Terra L Lasho, Christy M Finke, Animesh Pardanani, Naseema Gangat, Ryan M Carr, Moritz Binder, Abhishek A Mangaonkar, Rhett Ketterling, Martin E Fernandez-Zapico, Keith D Robertson, Alberto Bosi, Alessandro M Vannucchi, Ayalew Tefferi, Mirinal S Patnaik
Phenotypic correlates and prognostic outcomes of TET2 mutations in myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: A comprehensive study of 504 adult patients. American journal of hematology 95 (4) (2020)

Giacomo Coltro.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Giacomo Coltro